The molecule of the title compound, C~23~H~23~NO~4~S, adopts a folded conformation, with the cyclopentadienone ring and tosyl groups arranged in an almost face-to-face fashion. The pyrrolidine ring has an envelope conformation and the dihydropyran ring is in a half-chair conformation. The pyrrolidin
14b-Chloro-4a-methoxy-3,3-dimethyl-2,3,4a,14b-tetrahydro-1H-benzo[a]pyrano[2,3-c]phenazine: a new active structural type against Mycobacterium tuberculosis
✍ Scribed by Nunes, I. K. da C. ;De Simone, C. A. ;Silva, R. S. F. ;Pinto, A. V. ;Goulart, M. O. F.
- Book ID
- 104491436
- Publisher
- International Union of Crystallography
- Year
- 2007
- Tongue
- English
- Weight
- 763 KB
- Volume
- 63
- Category
- Article
- ISSN
- 1600-5368
No coin nor oath required. For personal study only.
✦ Synopsis
The title compound, C 22 H 21 ClN 2 O 2 , obtained from the reaction of the phenazine of -lapachone with trichloroisocyanuric acid, showed a minimum inhibitory concentration of 6.25 ng ml À1 in tuberculostatic assays against Mycobacterium tuberculosis and established a new structural type with potential interest in medicinal chemistry. The dihydropyran ring adopts a pure chair conformation, while the ring fused to it has a half-chair conformation. The two substituents, OMe and Cl, are in axial positions, due to anomeric effects towards the methoxy derivative.
Related literature
For general background, see:
📜 SIMILAR VOLUMES
## Abstract ^14^C‐Labelled (S)‐(+)‐6‐(2‐chlorophenyl)‐3‐cyclopropanecarbonyl‐8,11‐dimethyl‐2,3,4,5‐ tetrahydro‐8H‐pyrido[4′,3′:4,5]thieno[3,2‐f][1,2,4]triazolo[4,3‐a][1,4] diazepine (^14^C‐E6123), a platelet activating factor receptor antagonist for studying the pharmacokinetic profile of E6123, wa